Collaborations and top research areas from the last five years
Projects
- 6 Finished
-
Impact of T-cell Repertoire on Risk of CMV Reactivation in Patients Post Hematopoietic Stem Cell Transplantation
Al-Khabori, M. (PI)
12/1/21 → 8/31/23
Project: MoHERI
-
Variability of Rivaroxaban Pharmacokinetics and its Genetic Predictors
Al-Khabori, M. (PI)
1/1/20 → 12/31/21
Project: Internal Grants (IG)
-
Proteomics as Minimal Residual Disease Assessment in Patients with Acute Myeloid Leukemia
Al-Khabori, M. (PI)
9/1/19 → 2/28/22
Project: MoHERI
-
Coagulation Factor VIII Population Based Pharmacokinetics in Patients with Hemophilia A
Al-Khabori, M. (PI)
11/15/18 → 11/14/19
Project: MoHERI
-
Impact of Mutations in the Epigenetic Regulators on the Presentation and Outcome of Patients with Myeloproliferative Neoplasma
Al-Khabori, M. (PI)
1/1/16 → 12/31/17
Project: Internal Grants (IG)
-
Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries
Prats, J. A. G. G., Farsi, K. A., Al-Khabori, M., Al-Saadawi, N., Alshemmari, S. H., Cherif, H., Ibrahim, D., Kaloyannidis, P. & Swaka, R. L. S. W., Feb 6 2026, (E-pub ahead of print) In: BMC Infectious Diseases.Research output: Contribution to journal › Article › peer-review
-
Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries
Prats, J. A. G. G., Farsi, K. A., Al-Khabori, M., Al-Saadawi, N., Alshemmari, S. H., Cherif, H., Ibrahim, D., Kaloyannidis, P. & Swaka, R. L. S. W., Dec 2026, In: BMC Infectious Diseases. 26, 1, 498.Research output: Contribution to journal › Article › peer-review
Open Access -
Effects of glutathione-S-transferase polymorphisms on intravenous busulfan in hematopoietic stem cell transplant patients: a meta-analysis
Salman, B., Al Riyami, I., Al Maskari, R. & Al Khabori, M., Mar 2026, In: Pharmacogenetics and Genomics. 36, 2, p. 32-47 16 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial
BASIS Investigators, Feb 26 2026, In: Blood. 147, 9, p. 920-931 12 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study
Matino, D., Palladino, A., Taylor, C. T., Hwang, E., Raje, S., Nayak, S., McDonald, R., Acharya, S. S., Mahlangu, J., Jimenez-Yuste, V., Choraria, N., Yang, R., Li, C. K., Al-Khabori, M., Wali, Y., Adrian, J. M., Park, Y.-S., Zülfikar, O. B. & Teeter, J., 2026, In: Therapeutic Advances in Hematology. 17, p. 20406207261430259Research output: Contribution to journal › Review article › peer-review
Press/Media
-
Oman Medical Specialty Board Researchers Describe Research in Anions (Molecular Characterization of Glucose-6-phosphate Dehydrogenase Deficiency in Oman)
1/31/24
1 item of Media coverage
Press/Media: Press / Media
-
Sultan Qaboos University Hospital Reports Findings in Hematopoietic Stem Cells (Limited Sampling Strategy Using End of Infusion and Six-Hour Concentrations Overestimates Intravenous Busulfan Clearance Compared With Standard Six-Point Sampling ...)
8/8/23
1 item of Media coverage
Press/Media: Press / Media
-
Qatar University Researcher Provides New Data on Artificial Intelligence (Applications of Artificial Intelligence in Thrombocytopenia)
3/24/23
1 item of Media coverage
Press/Media: Press / Media